¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

Á¦10ȸ ¿µ³²´ëÇб³º´¿ø ½ÉÀå³»°ú ½ÉÆ÷Áö¾ö : 2024-02-03

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 

Á¦10ȸ ¿µ³²´ëÇб³º´¿ø ½ÉÀå³»°ú ½ÉÆ÷Áö¾ö : 2024-02-03
±³À°ÀÏÀÚ : 2024-02-03
±³À°Àå¼Ò : ´ë±¸ ±×·£µå È£ÅÚ 2Ãþ ´ÙÀ̳ʽºÆ¼ BȦ

±³À°ÁÖÁ¦ : Á¦10ȸ ¿µ³²´ëÇб³º´¿ø ½ÉÀå³»°ú ½ÉÆ÷Áö¾ö

ÁÖÃÖ±â°ü : ¿µ³²´ëÇб³º´¿ø
½ÃÇà±â°ü(ÁöºÎ/°ú) : ³»°ú

´ã´çÀÚ : ³²Á¾È£
¿¬¶ôó : 010-9064-5960

À̸ÞÀÏ : 16njh@naver.com

±³À°Á¾·ù : ³»°ú

Âü¼®¿¹»óÀÎ : 100¸í
Èñ¸ÁÆòÁ¡ : 4Á¡

Áö¿ª : ´ë±¸±¤¿ª½Ã
±³À°½Ã°£ : 5 ½Ã°£ 0ºÐ

¼¼ºÎ¼ö°­·á : 0¿ø  

ºñ°í


±¸ºÐ ¿ùÀÏ °­ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ

±³À°½Ã°£ 02¿ù 03ÀÏ ´ë±¸±×·£µåÈ£ÅÚ 2Ãþ ´ÙÀ̳ʽºÆ¼ BȦ 13:00~13:15 Lifetime management of patients with severe AS ±è¿õ(¿µ³²ÀÇ´ë)

±³À°½Ã°£ 02¿ù 03ÀÏ ´ë±¸±×·£µåÈ£ÅÚ 2Ãþ ´ÙÀ̳ʽºÆ¼ BȦ 13:15~13:30 Management strategies for heavily calcified coronary artery stenosis ¹ÚÁ¾ÀÏ(¿µ³²ÀÇ´ë)

±³À°½Ã°£ 02¿ù 03ÀÏ ´ë±¸±×·£µåÈ£ÅÚ 2Ãþ ´ÙÀ̳ʽºÆ¼ BȦ 13:30~13:50 Treatment strategies for coronary bifurcation lesions Á¤¼ºÀ±(¿ï»êµ¿°­)

Åä·Ð 02¿ù 03ÀÏ ´ë±¸±×·£µåÈ£ÅÚ 2Ãþ ´ÙÀ̳ʽºÆ¼ BȦ 13:50~14:00 Åä·Ð Á¶Çö¼ö(Æ÷Ç×¼¼¸í±âµ¶)

±³À°½Ã°£ 02¿ù 03ÀÏ ´ë±¸±×·£µåÈ£ÅÚ 2Ãþ ´ÙÀ̳ʽºÆ¼ BȦ 14:00~14:15 How to set up TEER for MR in our echo lab È«±×·ç(¿¬¼¼ÀÇ´ë)

±³À°½Ã°£ 02¿ù 03ÀÏ ´ë±¸±×·£µåÈ£ÅÚ 2Ãþ ´ÙÀ̳ʽºÆ¼ BȦ 14:15~14:30 Assessment of true severity of AS: Case-based learning ¼ÕÀå¿ø(¿µ³²ÀÇ´ë)

±³À°½Ã°£ 02¿ù 03ÀÏ ´ë±¸±×·£µåÈ£ÅÚ 2Ãþ ´ÙÀ̳ʽºÆ¼ BȦ 14:30~14:50 Advances in assessment of secondary TR ³²Á¾È£(¿µ³²ÀÇ´ë)

Åä·Ð 02¿ù 03ÀÏ ´ë±¸±×·£µåÈ£ÅÚ 2Ãþ ´ÙÀ̳ʽºÆ¼ BȦ 14:50~15:00 Åä·Ð ÀÌ¿øÀç(¿µ³²ÀÇ´ë)

ÈÞ½Ä 02¿ù 03ÀÏ ´ë±¸±×·£µåÈ£ÅÚ 2Ãþ ´ÙÀ̳ʽºÆ¼ BȦ 15:00~15:20 ÈÞ½Ä ( )

±³À°½Ã°£ 02¿ù 03ÀÏ ´ë±¸±×·£µåÈ£ÅÚ 2Ãþ ´ÙÀ̳ʽºÆ¼ BȦ 15:20~15:35 PACs: clinical implication, diagnosis, and treatment ¹Ú±Ôȯ(´ë±¸º¸ÈÆ)

±³À°½Ã°£ 02¿ù 03ÀÏ ´ë±¸±×·£µåÈ£ÅÚ 2Ãþ ´ÙÀ̳ʽºÆ¼ BȦ 15:35~15:50 Indication for conduction system pacing Á¶¹Î¼ö(¼­¿ï¾Æ»ê)

±³À°½Ã°£ 02¿ù 03ÀÏ ´ë±¸±×·£µåÈ£ÅÚ 2Ãþ ´ÙÀ̳ʽºÆ¼ BȦ 15:50~16:10 Single shot technique for rhythm control of AF ±èÈ«ÁÖ(¿¬¼¼ÀÇ´ë)

Åä·Ð 02¿ù 03ÀÏ ´ë±¸±×·£µåÈ£ÅÚ 2Ãþ ´ÙÀ̳ʽºÆ¼ BȦ 16:10~16:20 Åä·Ð ÀÌ»óÈñ(Æ÷Ç×¼¼¸í±âµ¶)

±³À°½Ã°£ 02¿ù 03ÀÏ ´ë±¸±×·£µåÈ£ÅÚ 2Ãþ ´ÙÀ̳ʽºÆ¼ BȦ 16:20~16:35 Recent Update of New Drugs in HF: Vericiguat and Mavacamten °­»ó¿í(´ë±¸º¸ÈÆ)

±³À°½Ã°£ 02¿ù 03ÀÏ ´ë±¸±×·£µåÈ£ÅÚ 2Ãþ ´ÙÀ̳ʽºÆ¼ BȦ 16:35~16:50 What¡¯s new and what has changed in 2023 ESH HTN guideline? ÀÌÇö¿í(°è¸íÀÇ´ë)

±³À°½Ã°£ 02¿ù 03ÀÏ ´ë±¸±×·£µåÈ£ÅÚ 2Ãþ ´ÙÀ̳ʽºÆ¼ BȦ 16:50~17:10 Obesity in HF ÃÖ°­¿î(¿µ³²ÀÇ´ë)

Åä·Ð 02¿ù 03ÀÏ ´ë±¸±×·£µåÈ£ÅÚ 2Ãþ ´ÙÀ̳ʽºÆ¼ BȦ 17:10~17:20 Åä·Ð ¹èÁØÈ£(Æ÷Ç×¼¼¸í±âµ¶)

Åä·Ð 02¿ù 03ÀÏ ´ë±¸±×·£µåÈ£ÅÚ 2Ãþ ´ÙÀ̳ʽºÆ¼ BȦ 17:20~17:35 Case-based discussion : coronary artery anomaly ±èÈÆÅÂ(Æ÷Ç×¼¼¸í±âµ¶)

Åä·Ð 02¿ù 03ÀÏ ´ë±¸±×·£µåÈ£ÅÚ 2Ãþ ´ÙÀ̳ʽºÆ¼ BȦ 17:35~17:50 Case-based discussion : coronary artery intervention ±èº´ÁØ(â¿øÇѸ¶À½)

Åä·Ð 02¿ù 03ÀÏ ´ë±¸±×·£µåÈ£ÅÚ 2Ãþ ´ÙÀ̳ʽºÆ¼ BȦ 17:50~18:10 Case-based discussion : peripheral artery intervention ¹Ú¼¼Çö(´ë±¸º¸ÈÆ)

Åä·Ð 02¿ù 03ÀÏ ´ë±¸±×·£µåÈ£ÅÚ 2Ãþ ´ÙÀ̳ʽºÆ¼ BȦ 18:10~18:20 Åä·Ð ¼ÕÀå¿ø(¿µ³²ÀÇ´ë)

 

ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" Á¦10ȸ ¿µ³²´ëÇб³º´¿ø ½ÉÀå³»°ú ½ÉÆ÷Áö¾ö : 2024-02-03""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û 2024³â ´ëÇѼÒÈ­±â³»½Ã°æÇÐȸ ³»½Ã°æ ¾ÆÄ«µ¥¹Ì Åõ¾î (ÀüºÏ) : 2024-02-03
´ÙÀ½±Û ´Ù¹ß°ñ¼öÁ¾¿¬±¸È¸ Update on MM 2024(ASH review) : 2024-02-03
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
103 ¼­¿ï ´ëÇѼҾƽŰæÇÐȸ Fellowship in Training : 2018-08-25 0 525 2018-07-28
102 °æ±â Á¦5Â÷ ¾Æ½Ã¾ÆºÎÀÎÁ¾¾çÇÐȸ ¿öÅ©¼ó(ASGO 5th International Workshop on Gynecologic Oncology in conjunction with 12th KSGO Workshop for Young Gynecologic Oncologists) : 2018-08-25 0 319 2018-07-28
101 ¼­¿ï 2018³â ´ëÇѺÎÀ§¸¶ÃëÇÐȸ Á¦2ȸ Çмú´ëȸ : 2018-08-25 0 461 2018-07-28
100 ÀüºÏ Á¦ 67ȸ Çѳ² ÇǺΰúÇÐȸ Çмú´ëȸ : 2018-08-25 0 1,062 2018-07-28
99 °æºÏ Ä¥°î°æºÏ´ëÇб³º´¿ø °æºÏ´ëÇб³ ÀÇ°ú´ëÇÐ ¸¶ÃëÅëÁõÀÇÇаú ÇÏ°è ½ÉÆ÷Áö¾ö : 2018-08-25 0 617 2018-07-28
98 °æ±â ´ëÇѽŰæ±Ù°ñ°ÝÃÊÀ½ÆÄÇÐȸ Á¦3ȸ ÇÚÁî¿Â ¿öÅ©¼ó Á¦1ºÎ : 2018-08-25 0 357 2018-07-28
97 °æ±â ´ëÇѽŰæ±Ù°ñ°ÝÃÊÀ½ÆÄÇÐȸ Á¦3ȸ ÇÚÁî¿Â ¿öÅ©¼ó Á¦2ºÎ : 2018-08-25 0 872 2018-07-28
96 ´ëÀü 2018³â ´ëÇÑÅëÁõÇÐȸ Áö¹æ¼øȸ ÃÊÀ½ÆÄ ¹× °æ¸·¿Ü³»½Ã°æWorkshop_Live Surgery with Epiduroscopy : 2018-08-24 0 325 2018-07-28
95 ÀÎõ 2018³â ´ëÇѺҾÈÀÇÇÐȸ Çϰ迬¼ö±³À° : 2018-08-24 0 298 2018-07-28
94 ÃæºÏ ±¹¸³ÀÇ·á¿ø ÃÊÀ½ÆÄ À¯µµÇÏ ½Ã¼ú ¹× ±Ù°ñ°Ý°è ÃÊÀ½ÆÄ ¿ª·® °­È­ : 2018-08-24 0 334 2018-07-28
93 ºÎ»ê ´ëÇѽŰæÁßÀçÄ¡·áÀÇÇÐȸ Summer Intensive Course 2018 of KSIN : 2018-08-24 0 376 2018-07-28
92 ¼­¿ï 2018³â ½ÅÁ¾ ¹× »ý¹°Å×·¯°¨¿°º´ ´ëÀÀÀü¹®¿ä¿ø ±³À°[»çÀüµî·Ï Çʼö] : 2018-08-24 0 296 2018-07-28
91 ¼­¿ï 2018³â ´ëÇÑ°©»ó¼±ÇÐȸ Ãß°èÇмú´ëȸ(8/24) : 2018-08-24 0 306 2018-07-28
90 ÀÎõ °­È­±ºÀÇ»çȸ 3Â÷ ¼¼¹Ì³ª(°üÀýº¸Á¸ Ä¡·á) : 2018-08-24 0 292 2018-07-28
89 °æ±â Á¦5Â÷ ¾Æ½Ã¾ÆºÎÀÎÁ¾¾çÇÐȸ ¿öÅ©¼ó(ASGO 5th International Workshop on Gynecologic Oncology in conjunction with 12th KSGO Workshop for Young Gynecologic Oncologists) : 2018-08-24 0 465 2018-07-28
1391 | 1392 | 1393 | 1394 | 1395 | 1396 | 1397 | 1398 | 1399 | 1400
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷